SCHEMBL10114103

SCHEMBL10114103

COc1ccc2c(c1)C(=O)N(c1ccc(C(C)(C)C)cc1)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.59
▸ RAB9A P51151 5/20 0.59
▸ PKM P14618 2/20 0.59
▸ POLB P06746 2/20 0.48
▸ GAA P10253 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ ESR1 P03372 1/20 0.43
▸ NR4A1 P22736 1/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ PTPN7 P35236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10086533 0.87 NPC1 (0.53) NPC1RAB9APKMPOLBGAA
SCHEMBL10086551 0.85 NPC1 (0.45) NPC1RAB9APKMPOLBGAA
SCHEMBL10086218 0.85 KMT2A (0.64) NPC1RAB9APKMPOLBGAA
SCHEMBL10085914 0.82 NPC1 (0.56) NPC1RAB9APKMGAAKMT2A
SCHEMBL2192236 0.82 NPC1 (0.59) NPC1RAB9APKMPOLBGAA
SCHEMBL10085800 0.82 NPC1 (0.59) NPC1RAB9APKMPOLBGAA
SCHEMBL10086209 0.81 NPC1 (0.44) NPC1RAB9APKMGAAKMT2A
SCHEMBL10086415 0.81 NPC1 (0.58) NPC1RAB9APKMPOLBGAA
SCHEMBL10085507 0.81 NPC1 (0.58) NPC1RAB9APKMPOLBGAA
SCHEMBL1468548 0.80 NPC1 (0.68) NPC1RAB9APKMPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 — — US disclosed
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 — — US disclosed
Send feedback